Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ (DCIS) Patient Population at Low-risk of Upgrade to Invasive Carcinoma?

被引：0
|
作者：
Pilewskie, M. [1 ]
Stempel, M. [1 ]
Rosenfeld, H. [1 ]
Eaton, A. [1 ]
Van Zee, K. J. [1 ]
Morrow, M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52
引用
下载
收藏
页码：S25 / S26
页数：2
相关论文
共 50 条
  • [31] Upgrade to Invasive Carcinoma or Ductal Carcinoma In Situ (DCIS) in Patients Diagnosed with Lobular Neoplasia (LN) on Core Needle Biopsy (CNB): A Prospective Study
    Gilmore, L.
    Schnitt, S.
    Nakhlis, F.
    LABORATORY INVESTIGATION, 2014, 94 : 50A - 50A
  • [32] Upgrade to Invasive Carcinoma or Ductal Carcinoma In Situ (DCIS) in Patients Diagnosed with Lobular Neoplasia (LN) on Core Needle Biopsy (CNB): A Prospective Study
    Gilmore, L.
    Schnitt, S.
    Nakhlis, F.
    MODERN PATHOLOGY, 2014, 27 : 50A - 50A
  • [33] Treatment of low-risk ductal carcinoma in situ: is nothing better than something?
    Benson, John R.
    Jatoi, Ismail
    Toi, Masakazu
    LANCET ONCOLOGY, 2016, 17 (10): : E442 - E451
  • [34] De-Escalating Breast or Low-Risk Ductal Carcinoma in Situ Reply
    Morrow, Monica
    Winer, Eric
    JAMA ONCOLOGY, 2020, 6 (07) : 1118 - 1118
  • [35] Can we avoid treatment in patients with low-risk ductal carcinoma in situ?
    Fuentes-Sanchez, Claudio
    Gonzalez-San Segundo, Carmen
    ANNALS OF BREAST SURGERY, 2023, 7
  • [36] Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis
    Rakovitch, Eileen
    Nofech-Mozes, Sharon
    Narod, Steven A.
    Hanna, Wedad
    Thiruchelvam, Deva
    Saskin, Refik
    Taylor, Carole
    Tuck, Alan
    Sengupta, Sandip
    Elavathil, Leela
    Jani, Prashant A.
    Done, Susan J.
    Miller, Naomi
    Youngson, Bruce
    Kong, Iwa
    Paszat, Lawrence
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (02) : 581 - 590
  • [37] Identifying a Low-risk Group for Residual Disease in Patients with Ductal Carcinoma In Situ
    Murphy, B. L.
    Gonzalez, A.
    Conners, A. L.
    Henrichsen, T. L.
    Keeney, M. G.
    Chen, B.
    Nguyen, T. T.
    Shah, H. N.
    Harmsen, W.
    Habermann, E. B.
    Jakub, J. W.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S58 - S58
  • [38] Evolving Treatment Paradigms for Low-Risk Ductal Carcinoma In Situ: Imaging Needs
    Nguyen, Derek L.
    Greenwood, Heather I.
    Rahbar, Habib
    Grimm, Lars J.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2024, 222 (03)
  • [39] De-Escalating Treatment of Low-Risk Breast Ductal Carcinoma In Situ
    Lazzeroni, Matteo
    DeCensi, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (12) : 1252 - +
  • [40] Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis
    Eileen Rakovitch
    Sharon Nofech-Mozes
    Steven A. Narod
    Wedad Hanna
    Deva Thiruchelvam
    Refik Saskin
    Carole Taylor
    Alan Tuck
    Sandip Sengupta
    Leela Elavathil
    Prashant A. Jani
    Susan J. Done
    Naomi Miller
    Bruce Youngson
    Iwa Kong
    Lawrence Paszat
    Breast Cancer Research and Treatment, 2013, 138 : 581 - 590
12345